RDY - Dr. Reddy's acquires 6.46% stake in Israeli biotech Edity Therapeutics
2023-12-29 14:52:48 ET
More on Dr. Reddy's
- Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements
- Dr Reddy's Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript
- Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investment Outlook
- Dr. Reddy's falls as FDA flags concerns on factory site
- Dr Reddy's licenses Coya ALS candidate in exclusive deal
For further details see:
Dr. Reddy's acquires 6.46% stake in Israeli biotech Edity Therapeutics